Enterprise record
Alpha ID: alpha:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6Version: public-1
27 published Claims6 sources
The enterprise, in context.
Connect capital, control, accountability, and evidence.
Governance priorities
Capital allocationInspect reported performance, cash generation, and investment.Board accountabilityWho holds each mandate, and what evidence supports it?Ownership & votingSeparate economic interests from voting authority.Key Claims
Board and committees
Financial statements
Published financial observations retain their reported values, periods, and sources. Coverage may be partial; this is not a reconstructed complete financial statement.
All financials coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageControl and shareholders
Control and shareholders coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageCompensation
Compensation coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageAuditors, advisors and reporting
Auditors, advisors and reporting coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageLegal
Legal coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageAI governance
AI governance coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageEvidence, history and coverage
Additional published Claims
Published evidence records
6 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
Alpha canonical company public projection
canonical identity · Source published: Date unavailable · Retrieved: Sep 30, 2026
Supports 5 claims
- Legal Name: Lineage Cell Therapeutics, Inc. · Claim reviewed: Sep 30, 2026
- Entity Status: Public listing published · Claim reviewed: Sep 30, 2026
- Published Fact: US · Claim reviewed: Sep 30, 2026
- Published Fact: Healthcare · Claim reviewed: Sep 30, 2026
- Published Fact: Biotechnology · Claim reviewed: Sep 30, 2026
SEC DEF 14A 0001193125-26-191556
sec def 14a · Source published: Apr 29, 2026 · Retrieved: Sep 6, 2026
Supports 4 claims
- Leadership Role: Michael H. Mulroy: Chairman of the Board · Claim reviewed: Sep 30, 2026
- Leadership Role: Brian M. Culley: Chief Executive Officer · Claim reviewed: Sep 30, 2026
- Leadership Role: George A. Samuel III: General Counsel and Corporate Secretary · Claim reviewed: Sep 30, 2026
- Leadership Role: Jill A. Howe: Chief Financial Officer · Claim reviewed: Sep 30, 2026
DEF 14A lctx-20260429.htm
sec proxy · Source published: Apr 29, 2026 · Retrieved: Sep 2, 2026
Supports 8 claims
- Leadership Role: Angus C. Russell: Director · Claim reviewed: Sep 30, 2026
- Leadership Role: Anula Jayasuriya: Director · Claim reviewed: Sep 30, 2026
- Leadership Role: Brian M. Culley: Director · Claim reviewed: Sep 30, 2026
- Leadership Role: By Mail: Director · Claim reviewed: Sep 30, 2026
- Leadership Role: Deborah Andrews: Director · Claim reviewed: Sep 30, 2026
- Leadership Role: Dipti Amin: Director · Claim reviewed: Sep 30, 2026
- Leadership Role: George A. Samuel III: Director · Claim reviewed: Sep 30, 2026
- Leadership Role: Neal C. Bradsher: Director · Claim reviewed: Sep 30, 2026
Audit Committee
sec proxy · Source published: Date unavailable · Retrieved: Date unavailable
Supports 3 claims
- Committee Record: Audit Committee: Chair Deborah Andrews; Members Deborah Andrews (Chair); Angus C. Russell · Claim reviewed: Sep 30, 2026
- Committee Appointment: Deborah Andrews: chair, Audit Committee · Claim reviewed: Sep 30, 2026
- Committee Appointment: Angus C. Russell: member, Audit Committee · Claim reviewed: Sep 30, 2026
Compensation Committee
sec proxy · Source published: Date unavailable · Retrieved: Date unavailable
Supports 4 claims
- Committee Record: Compensation Committee: Chair Angus C. Russell; Members Angus C. Russell (Chair); Deborah Andrews; Dipti Amin · Claim reviewed: Sep 30, 2026
- Committee Appointment: Angus C. Russell: chair, Compensation Committee · Claim reviewed: Sep 30, 2026
- Committee Appointment: Deborah Andrews: member, Compensation Committee · Claim reviewed: Sep 30, 2026
- Committee Appointment: Dipti Amin: member, Compensation Committee · Claim reviewed: Sep 30, 2026
Nominating & Corporate Governance Committee
sec proxy · Source published: Date unavailable · Retrieved: Date unavailable
Supports 3 claims
- Committee Record: Nominating & Corporate Governance Committee: Chair Neal C. Bradsher; Members Neal C. Bradsher (Chair); Anula Jayasuriya · Claim reviewed: Sep 30, 2026
- Committee Appointment: Neal C. Bradsher: chair, Nominating & Corporate Governance Committee · Claim reviewed: Sep 30, 2026
- Committee Appointment: Anula Jayasuriya: member, Nominating & Corporate Governance Committee · Claim reviewed: Sep 30, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
source reported
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-09-30
- Board and committees
- published
- Financial statements
- not observed
- Control and shareholders
- not observed
- Compensation
- not observed
- Auditors, advisors and reporting
- not observed
- Legal
- not observed
- AI governance
- not observed